Allocations
Pomona Capital has launched the Pomona Investment Fund, distributed by Voya Investments Distributor. With a USD25,000 minimum subscription requirement and an investor friendly tax reporting structure, the fund is designed to give accredited investors easier access to private equity investing.
Pomona Investment Fund seeks to offer broad exposure to a portfolio of private equity investments managed by experienced general partners. The majority of its investments are planned for secondary interests in seasoned private equity funds, with a supplementary focus on primary and direct commitments. Similar to Pomona's institutional fund offerings, the fund's strategy seeks the long-term capital appreciation associated with
International Capital Flows, a report commissioned by the States of Guernsey and supported by Guernsey Finance, has analysed the economic benefits provided to the UK and Europe by the Guernsey funds market.
The majority of the inward investment is deployed into long-term tangible assets, including private equity, infrastructure and commercial property. All of these asset classes can provide economic and social benefits to the UK.
The report estimates that European investment managers earn GBP1.8bn of fees from managing Guernsey funds, of which GBP1.1bn is earned by those in the UK. UK investors, such as pension funds, also benefit from using
Mission Bay Capital, a seed-stage venture firm investing in life science companies emerging from the University of California and the San Francisco Bay Area ecosystem, has closed MBC Fund II at USD25 million.
MBC was created in August 2009 by QB3, a University of California research institute and accelerator.
"We help early-stage entrepreneurial scientists change the world," says Douglas Crawford, associate director of QB3 and managing partner of MBC. "Closing Fund II will enable us to continue providing the capital and support that our companies need to bring their innovative technologies to market."
Three MBC Fund I companies – Calithera,
Mooreland Partners acted as the exclusive financial advisor to Luna Innovations Incorporated (LUNA) on its merger with Advanced Photonix, Inc (API).
The combined company will keep the Luna name and be headquartered in Roanoke, Virginia, and will have a strong product foundation with Luna Innovations' ("Luna") core test & measurement products and Advanced Photonix's ("API") High Speed Optical Receiver (HSOR) and Optosolutions product lines. Stockholders from both companies approved the transaction on 8 May, 2015.
"The merger of API and Luna will result in a much larger, yet more cost efficient company. The combined new company will have the resources
CIT Group has served as Sole Lead Arranger and Administrative Agent in a USD90 million senior secured credit facility to support vXchnge Holdings’ (vXchnge) acquisition of eight datacenters.
vXchnge is a portfolio company of The Stephens Group, a private equity firm located in Little Rock, Arkansas. Financing was provided by CIT Bank, the U.S. commercial bank subsidiary of CIT.
“We are pleased to provide this acquisition financing to vXchnge to help position the company to meet the increasing demand for secure and scalable datacenters”
Based in Tampa, Florida, vXchnge is a provider of colocation services and was formed in 2013
Risk Capital Partners, the private equity firm chaired by Luke Johnson, has bought a majority stake in Zoggs, the global swimming products brand.
Zoggs sells over 2.5 million pairs of goggles across 50 countries throughout the world. Founded in Sydney, Australia in 1992 it has built on its success as an innovator in the goggles market to develop a full range of swimwear, swim equipment and learn to swim/water confidence products.
Zoggs established and developed a market leading position in the UK leisure centre channel, servicing the majority of UK leisure centres with ‘point of use’ sales. In recent
Private equity firm Lonsdale Capital Partners has acquired a stake in Nutrisure Limited (Nutrisure), a supplier of superfoods both in the UK and internationally.
In the fast growing and increasingly popular world of organic superfoods, which includes spirulina, coconut oil and chia seeds, Nutrisure has seen a significant increase in demand for its products. This has helped it generate sales of GBP12.5million in the current financial year, and has also seen it included in the Sunday Times Virgin Fast Track 100 league table.
Lonsdale’s funds will help the company continue its strong growth to date, with investment in the Naturya
eve – the new e-commerce venture launched to wake up the sleepy mattress industry – has closed a GBP600,000 seed funding round, with venture capital firm Octopus joining initial investors DN Capital and FJ Labs with a GBP225,000 investment.
The original round, which was announced in February, was reopened due to unprecedented interest from new parties. This comes as eve launches services in Germany, just three months after launching in the UK.
Today’s announcement follows significant growth figures from the business, which is disrupting the mattress industry by delivering premium quality mattresses direct to consumers at a fraction of high
Colombian private equity fund manager Tribeca led the recent sale of Bogota Beer Company (BBC), Colombia’s leading craft brewer and pub operator, to AmBev, a leading brewer in Latin America.
Tribeca originally took a 40% stake in Bogota Beer Company in 2013, providing financing for an aggressive growth strategy that included increasing the number of pubs from 13 to 27 in the first two years, as well as the construction of a 280,000-hectoliters-per-annum state-of-the-art production facility near Bogota (up 14 fold versus previous production facility).
During the same period, Bogota Beer Company expanded its geographical presence to Medellin, Cartagena, Barranquilla
KEPRO, in partnership with private equity fund Consonance Capital Partners, has acquired APS Healthcare from Universal American.
The combination will enhance KEPRO’s ability to provide a comprehensive and high quality set of service offerings through an integrated approach to medical management – an area that will continue to experience strong growth as a result of shifting reimbursement models and changing regulatory requirements. The company’s wide breadth of services will continue to include member centric care management solutions, physical and behavioural health utilisation management, employee assistance and absence management programs, as well as other offerings such as pre-admission screening and resident
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
